Analysis of cross-over studies with missing data

Statistical Methods in Medical Research

Volumn 24, Issue 4, 2015, Pages 420-433

  Rosenkranz, Gerd K ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

cross over trials; fixed effects model; missing data; mixed effects model; sensitivity analyses

Indexed keywords

ANALYSIS OF VARIANCE; BAYES THEOREM; DATA ANALYSIS; EXPERIMENTAL STUDY; HUMAN; MATHEMATICAL COMPUTING; MAXIMUM LIKELIHOOD METHOD; MEDICAL LITERATURE; MEDICAL RESEARCH; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SENSITIVITY ANALYSIS; SIMULATION; STATISTICAL ANALYSIS; STATISTICAL MODEL; STUDY DESIGN; CLINICAL TRIAL (TOPIC); CROSSOVER PROCEDURE;

CLINICAL TRIALS AS TOPIC; CROSS-OVER STUDIES; DATA INTERPRETATION, STATISTICAL;

EID: 84937915681     PISSN: 09622802     EISSN: 14770334     Source Type: Journal    
DOI: 10.1177/0962280214521349     Document Type: Review

References (20)

1. CHMP. Guideline on missing data in confirmatory clinical trials, European Medicines Agency, 2011.
2. Grizzle JE,. The two-period change-over design and its use in clinical trial. Biometrics 1965; 21: 467-480.
3. Patel HI,. Analysis of incomplete data in a two-period crossover design with reference to clinical trials. Biometrika 1985; 72: 41-418.
4. Kenward MG, Molenberghs G,. Likelihood based frequentist inference when data are missing at random. Stat Sci 1998; 13: 236-247.
5. Lee JY, Kim BC, Park SG,. Average bioequivalence for two-sequence two period crossover design with incomplete data. J Biopharm Stat 2005; 15: 857-867.
6. Richardson BA, Flack VF,. The analysis of incomplete data in the three-period two-treatment cross-over design for clinical trials. Stat Med 1996; 15: 127-143.
7. Chow SC, Shao J,. Statistical methods for two-sequence three-period cross-over designs with incomplete data. Stat Med 1997; 16: 103-1039.
8. Jones B, Kenward MG,. Design and analysis of cross-over trials, 2nd ed. London: Chapman and Hall, 2003.
9. Basu S, Santra S,. A joint model for incomplete data in crossover trials. J Stat Plan Infer 2010; 140: 2839-2845.
10. Diggle P, Kenward MG,. Informative drop-out in longitudinal data analysis. Appl Stat 1994; 43: 457-472.
11. CHMP. Guideline on the investigation of bioequivalence, European Medicines Agency, 2010.
12. Guidance for industry: statistical approaches to establishing bioequivalence. Food and Drug Administration, 2001.
13. Rubin DB,. Inference and missing data. Biometrika 1976; 63: 58-592.
14. Kenward MG,. Selection models for repeated measurements with non-random dropout: an illustration of sensitivity. Stat Med 1998; 17: 2723-2732.
15. Molenberghs G, Verbeke G, Thijs H,. Influence analysis to assess sensitivity of the dropout process. Comput Stat Data Anal 2001; 37: 93-113.
16. Kenward MG, Roger JH,. The use of baseline covariates in crossover studies. Biostatistics 2010; 11: 1-17.
17. Kenward MG, Roger JH,. Small sample inference for fixed effects from restricted maximum likelihood. Biometrics 1997; 53: 983-997.
18. SAS Institute Inc. SAS/STAT 9.22 user™s guide, Cary, NC: SAS Institute Inc., 2010.
19. Molenberghs G, Beunckens C, Sotto C,. Every missing not at random model has got a missing at random counterpart with equal fit. J R Stat Soc Ser B 2008; 70: 37-388.
20. Liu Q, Pierce DA,. A note on Gauss-Hermite quadrature. Biometrika 1994; 81: 624-629.